XML 21 R11.htm IDEA: XBRL DOCUMENT v3.19.2
Derivative Instruments
6 Months Ended
Jun. 30, 2019
Derivative Instruments And Hedging Activities Disclosure [Abstract]  
Derivative Instruments

5.

DERIVATIVE INSTRUMENTS

The Company is exposed to certain risks relating to its ongoing business operations. The primary risk managed by the use of derivative instruments is foreign currency exchange risk.  The Company holds forward foreign currency exchange contracts that are not designated as any type of accounting hedge as defined by GAAP.  The Company uses these contracts to manage its exposure to exchange rate fluctuations on certain Company subsidiary cash, accounts receivable, accounts payable and other obligation balances that are denominated in currencies other than the entities’ functional currencies. The forward foreign exchange contracts are recognized on the balance sheet as either an asset or a liability measured at fair value. Gains and losses arising from recording the foreign exchange contracts at fair value are reported in earnings as offsets to the losses and gains reported in earnings arising from the re-measurement of the asset and liability balances into the applicable functional currencies. At June 30, 2019, and December 31, 2018, the Company had open forward foreign currency exchange contracts, all with

durations of one to three months, to buy or sell foreign currencies with U.S. dollar equivalent amounts of $31,445,860 and $28,870,081, respectively.

The fair values of the derivative instruments held by the Company on June 30, 2019, and December 31, 2018, are disclosed in Note 4. Derivative instrument gains and losses for the three- and six- month periods ended June 30, 2019 and 2018, were immaterial. For amounts reclassified out of accumulated other comprehensive income (loss) (AOCI) into earnings for the three and six month periods ended June 30, 2019 and 2018, see Note 12.